101 related articles for article (PubMed ID: 23276653)
1. Poly(lactic-co-glycolic) acid loaded nano-insulin has greater potentials of combating arsenic induced hyperglycemia in mice: some novel findings.
Samadder A; Das J; Das S; De A; Saha SK; Bhattacharyya SS; Khuda-Bukhsh AR
Toxicol Appl Pharmacol; 2013 Feb; 267(1):57-73. PubMed ID: 23276653
[TBL] [Abstract][Full Text] [Related]
2. Relative efficacies of insulin and poly (lactic-co-glycolic) acid encapsulated nano-insulin in modulating certain significant biomarkers in arsenic intoxicated L6 cells.
Samadder A; Das S; Das J; Khuda-Bukhsh AR
Colloids Surf B Biointerfaces; 2013 Sep; 109():10-9. PubMed ID: 23603037
[TBL] [Abstract][Full Text] [Related]
3. Ameliorative effects of Syzygium jambolanum extract and its poly (lactic-co-glycolic) acid nano-encapsulated form on arsenic-induced hyperglycemic stress: a multi-parametric evaluation.
Samadder A; Das S; Das J; Paul A; Khuda-Bukhsh AR
J Acupunct Meridian Stud; 2012 Dec; 5(6):310-8. PubMed ID: 23265083
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: mitochondria mediated apoptotic signalling cascades.
Das S; Das J; Samadder A; Paul A; Khuda-Bukhsh AR
Food Chem Toxicol; 2013 Dec; 62():670-80. PubMed ID: 24120900
[TBL] [Abstract][Full Text] [Related]
5. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
[TBL] [Abstract][Full Text] [Related]
6. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
7. Poly (lactide-co-glycolide) acid nanoencapsulation of a synthetic coumarin: cytotoxicity and bio-distribution in mice, in cancer cell line and interaction with calf thymus DNA as target.
Bhattacharyya SS; Paul S; De A; Das D; Samadder A; Boujedaini N; Khuda-Bukhsh AR
Toxicol Appl Pharmacol; 2011 Jun; 253(3):270-81. PubMed ID: 21549736
[TBL] [Abstract][Full Text] [Related]
8. Strategic formulation of apigenin-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro.
Das S; Das J; Samadder A; Paul A; Khuda-Bukhsh AR
Toxicol Lett; 2013 Nov; 223(2):124-38. PubMed ID: 24070738
[TBL] [Abstract][Full Text] [Related]
9. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
10. Development and structure of a novel barrier membrane composed of drug-loaded poly(lactic-co-glycolic acid) particles for guided bone regeneration.
Son JS; Kim SG; Jin SC; Piao ZG; Lee SY; Oh JS; Kim CS; Kim BH; Jeong MA
Biotechnol Lett; 2012 Apr; 34(4):779-87. PubMed ID: 22160329
[TBL] [Abstract][Full Text] [Related]
11. Poly (lactide-co-glycolide) encapsulated extract of Phytolacca decandra demonstrates better intervention against induced lung adenocarcinoma in mice and on A549 cells.
Das J; Das S; Samadder A; Bhadra K; Khuda-Bukhsh AR
Eur J Pharm Sci; 2012 Sep; 47(2):313-24. PubMed ID: 22771545
[TBL] [Abstract][Full Text] [Related]
12. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
14. Nano-Pelargonidin Protects Hyperglycemic-Induced L6 Cells against Mitochondrial Dysfunction.
Samadder A; Tarafdar D; Abraham SK; Ghosh K; Khuda-Bukhsh AR
Planta Med; 2017 Mar; 83(5):468-475. PubMed ID: 28073120
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis.
Amaral AC; Bocca AL; Ribeiro AM; Nunes J; Peixoto DL; Simioni AR; Primo FL; Lacava ZG; Bentes R; Titze-de-Almeida R; Tedesco AC; Morais PC; Felipe MS
J Antimicrob Chemother; 2009 Mar; 63(3):526-33. PubMed ID: 19151037
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles.
Yang J; Sun H; Song C
Diabetes Obes Metab; 2012 Apr; 14(4):358-64. PubMed ID: 22151795
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
[TBL] [Abstract][Full Text] [Related]
18. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier.
Nair KL; Thulasidasan AK; Deepa G; Anto RJ; Kumar GS
Int J Pharm; 2012 Apr; 425(1-2):44-52. PubMed ID: 22266528
[TBL] [Abstract][Full Text] [Related]
19. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of nanocurcumin in arsenic-exposed rats.
Sankar P; Telang AG; Suresh S; Kesavan M; Kannan K; Kalaivanan R; Sarkar SN
Int Immunopharmacol; 2013 Sep; 17(1):65-70. PubMed ID: 23747587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
